
Novartis loses out on its patent application for cancer drug Glivac in India. It says that will "discourage innovation". It's an important case in a country ...
france24englishAfter this week's Supreme Court verdict dismissing Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, we debate: Will...
ndtvIn a victory for health campaigners against big pharmaceuticals, India's supreme court rules that pharmaceutical giant Novartis cannot patent an updated vers...
channel4newsToday's best young talent will soon be changing the world. Novartis International Biotechnology Leadership Camp (BioCamp) offers top university students the ...
novartisCEO Joseph Jimenez says oncology will be an area of great medical breakthroughs in the next five to ten years.
cnnmoneyPatients, diseases and healthcare are changing - and this affects your health. © 2010 Novartis AG.
novartisSwiss drug maker Novartis has lost a battle in India's highest court to patent an updated version of its cancer drug Gilvec. The Supreme Court has dismissed ...
aljazeeraenglishhttp://www.euronews.com/ India's Supreme Court has rejected a request by Swiss drug-maker Novartis to patent an updated version of its cancer drug Glivec. Gl...
euronewsIn a landmark verdict, the Supreme Court of India dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glive...
ibnliveFrank Kellenberg von Novartis spricht mit uns im Interview über die Einstiegschancen und Karrieremöglichkeiten bei Novartis.
audimaxmedienDie Messer sind gewetzt: Daniel Vasella, nur noch heute Präsident von Novartis, tritt vor über 2688 Aktionäre. Die Mehrheit ist ihm schlecht gesinnt und wett...
bolzurichWofür sind Top-Manager verantwortlich? In welchen emotionalen Dynamiken entscheiden sie? - Dr. Daniel Vasella, langjähriger CEO und Verwaltungsratspräsident ...
heitgerconsultingThe Supreme Court on Monday dismissed Swiss drug-maker Novartis AG's attempt to win patent protection for its cancer drug Glivec. The ruling is said to have ...
ndtvSupreme Court Decision in Novartis case is a Victory for India : Cipla For a quick look at the Day's top business and finance stories, tune into ET Now Youtu...
etnowBlick.ch hat vor der Novartis-Generalversammlung die Aktionäre gefragt, mit welchem Gefühl sie an die GV gehen.
bolzurichDas indische Patentrecht erlaubt Armen weltweit den Zugang für die Grundversorgung mit Pharmazeutika. Sollte Novartis, welche mehr Gewinn für ihre Aktionäre ...
reasecplusSwiss Pharmaceutical company Novartis has lost its Indian patent case, which will enable India's generics company to continue producing cheaper copy cat vers...
dukascopytvAt noon on Wednesday the 19th September, MSF organised a flashmob in Geneva to protest against the action brought by the Swiss pharmaceutical company Novarti...
msfukThey Just Don't Get Novartis!
thestreettvSwiss pharma major Novartis AG today lost a seven-year long legal battle for getting its blood cancer drug Glivec patented in India and to restrain Indian co...
newsxliveNovartis: India rejects patent plea for cancer drug Glivec. India's Supreme Court has rejected a plea by Novartis to patent an updated version of its cancer ...
newsinworldnowCEO Joseph Jimenez discusses how Novartis pursues breakthrough drugs in comparison to its pharmaceutical competitors.
cnnmoneyIn a landmark verdict, the Supreme Court of India dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glive...
ibnliveAdam explains how drug companies may manipulate patent laws to maximise profits - a process known as "evergreening" - and speaks to Aziz Rehman from Médecins...
truthloaderIndia's Supreme Court has rejected the bid by Swiss drug company Novartis to patent what its says is a new version of its cancer drug. The ruling clears the ...
aljazeeraenglishIn February, Stop AIDS Campaign activists from across the UK took an international campaign against Novartis to the gates of their UK plant, demanding the Sw...
stopaidscampaign

